FR2104959B2 - - Google Patents

Info

Publication number
FR2104959B2
FR2104959B2 FR7032889A FR7032889A FR2104959B2 FR 2104959 B2 FR2104959 B2 FR 2104959B2 FR 7032889 A FR7032889 A FR 7032889A FR 7032889 A FR7032889 A FR 7032889A FR 2104959 B2 FR2104959 B2 FR 2104959B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7032889A
Other languages
French (fr)
Other versions
FR2104959A2 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7032889A priority Critical patent/FR2104959A2/fr
Priority to US00126929A priority patent/US3770724A/en
Priority to IL36474A priority patent/IL36474A/xx
Priority to PL1971147087A priority patent/PL83152B1/pl
Priority to CH422071A priority patent/CH546777A/fr
Priority to HURO609A priority patent/HU163769B/hu
Priority to CA109157A priority patent/CA937570A/en
Priority to BE765006A priority patent/BE765006A/xx
Priority to SU711633905A priority patent/SU505365A3/ru
Priority to JP46018828A priority patent/JPS5144960B1/ja
Priority to DK153171A priority patent/DK149345C/da
Priority to NL7104275.A priority patent/NL158497B/xx
Priority to ATA2739/71A priority patent/AT309699B/de
Priority to DE19712167043 priority patent/DE2167043A1/de
Priority to SE7405749A priority patent/SE390414B/xx
Priority to DE2167044A priority patent/DE2167044C2/de
Priority to SE7104214A priority patent/SE386179B/xx
Priority to DE2115718A priority patent/DE2115718C3/de
Priority to GB2578671*A priority patent/GB1351262A/en
Priority to GB2578671*A priority patent/GB1351263A/en
Priority to GB2578671*A priority patent/GB1351261A/en
Priority to ES394892A priority patent/ES394892A2/es
Publication of FR2104959A2 publication Critical patent/FR2104959A2/fr
Priority to AT430772A priority patent/AT336806B/de
Priority to CA153,612A priority patent/CA979452A/en
Priority to DK633373A priority patent/DK136475B/da
Application granted granted Critical
Publication of FR2104959B2 publication Critical patent/FR2104959B2/fr
Priority to JP12333275A priority patent/JPS5337360B2/ja
Priority to JP50123333A priority patent/JPS5227160B2/ja
Priority to IT8048032A priority patent/IT8048032A0/it
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR7032889A 1970-03-31 1970-09-10 Vincamine process Granted FR2104959A2 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
FR7032889A FR2104959A2 (en) 1970-09-10 1970-09-10 Vincamine process
US00126929A US3770724A (en) 1970-03-31 1971-03-22 Process for preparing pentacyclic alkaloids
IL36474A IL36474A (en) 1970-03-31 1971-03-23 Process for preparing pentacyclic alkaloids of the eburnamonine-vincamine series and novel e-homoeburnanes
PL1971147087A PL83152B1 (en) 1970-03-31 1971-03-23 Process for preparing pentacyclic alkaloids[us3770724a]
CH422071A CH546777A (fr) 1970-03-31 1971-03-23 Procede de preparation d'alcaloides pentacycliques.
HURO609A HU163769B (OSRAM) 1970-03-31 1971-03-25
BE765006A BE765006A (fr) 1970-03-31 1971-03-30 Procede de preparation d'alcaloides pentacycliques
SU711633905A SU505365A3 (ru) 1970-03-31 1971-03-30 Способ полуучени п тициклических алкалоидов
CA109157A CA937570A (en) 1970-03-31 1971-03-30 Procede de preparation de la vincamine racemique ou optiquement active
SE7104214A SE386179B (sv) 1970-03-31 1971-03-31 Sett att framstella vinkamin.
NL7104275.A NL158497B (nl) 1970-03-31 1971-03-31 Werkwijze voor de bereiding van vincamine of isovincamine.
ATA2739/71A AT309699B (de) 1970-03-31 1971-03-31 Verfahren zur herstellung pentacyclischer alkaloide
DE19712167043 DE2167043A1 (de) 1970-03-31 1971-03-31 Verfahren zur herstellung von optisch aktivem cis-1,2,3,4,6,7,12,12b-octahydro- 1-aethyl-1-carbomethoxyaethyl-indolo eckige klammer auf 2,3-a eckige klammer zu chinolizin
SE7405749A SE390414B (sv) 1970-03-31 1971-03-31 14,15-dioxo-e-homo-eburnaner som mellanprodukt for framstellning av vinkamin
JP46018828A JPS5144960B1 (OSRAM) 1970-03-31 1971-03-31
DK153171A DK149345C (da) 1970-03-31 1971-03-31 Fremgangsmaade til fremstilling af d,l-vincamin eller d,l-isovincamin eller de optiske antipoder deraf
DE2115718A DE2115718C3 (de) 1970-03-31 1971-03-31 Verfahren zur Herstellung von Vincamin und Isovincamin
DE2167044A DE2167044C2 (de) 1970-03-31 1971-03-31 E-homo-eburnanderivate
GB2578671*A GB1351262A (en) 1970-03-31 1971-04-19 Quinolizine derivatives
GB2578671*A GB1351263A (en) 1970-03-31 1971-04-19 Eburnane derivatives
GB2578671*A GB1351261A (en) 1970-03-31 1971-04-19 Preparation of vincamine alkaloids
ES394892A ES394892A2 (es) 1970-09-10 1971-09-08 Procedimiento de preparacion de alcaloides pentaciclicos.
AT430772A AT336806B (de) 1970-09-10 1972-05-17 Verfahren zur herstellung eines neuen enantiomers des cis-1,2,3,4,6,7-12,12b-octahydro-1-athyl-1-carbomethoxyathyl-indolo-(2,3-a)-chinolizins
CA153,612A CA979452A (en) 1970-03-31 1972-10-10 E-homo-eburnanes
DK633373A DK136475B (da) 1970-03-31 1973-11-23 Dioxoforbindelse til brug som mellemprodukt til fremstilling af vincamin og isovincamin, samt fremgangsmåde til fremstilling af denne dioxoforbindelse.
JP12333275A JPS5337360B2 (OSRAM) 1970-03-31 1975-10-15
JP50123333A JPS5227160B2 (OSRAM) 1970-03-31 1975-10-15
IT8048032A IT8048032A0 (it) 1970-03-31 1980-02-28 Procedimento per la produzione di alcaloidi pentaciclici

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7032889A FR2104959A2 (en) 1970-09-10 1970-09-10 Vincamine process

Publications (2)

Publication Number Publication Date
FR2104959A2 FR2104959A2 (en) 1972-04-28
FR2104959B2 true FR2104959B2 (OSRAM) 1974-02-01

Family

ID=9061144

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7032889A Granted FR2104959A2 (en) 1970-03-31 1970-09-10 Vincamine process

Country Status (2)

Country Link
ES (1) ES394892A2 (OSRAM)
FR (1) FR2104959A2 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2206090A1 (en) * 1972-11-16 1974-06-07 Omnium Chimique Sa Homovincamone-contg. medicaments - with vasodilating, spasmolytic anti-arrhythmic and anti-ischaemic properties
US4315011A (en) * 1978-07-12 1982-02-09 Richter Gedeon Vegyeszeti Gyar Rt. 1-Alkyl-9-bromohexahydroindolo quinolizium salts and use thereof to increase blood flow
FR2454808A1 (fr) * 1979-04-26 1980-11-21 Roussel Uclaf Application a titre de medicaments d'oximes derivees du e-homo eburnane, oximes derivees du e-homo eburnane et preparation
FR2492380A1 (en) * 1980-10-17 1982-04-23 Richter Gedeon Vegyeszet Optical antipodes of 14-oxo-E-homo-eburnane derivs. - useful as intermediates for cerebral vasodilators and their multistage prepn. from n-halo-pentanoyl-tryptophan derivs.

Also Published As

Publication number Publication date
ES394892A2 (es) 1977-07-01
FR2104959A2 (en) 1972-04-28

Similar Documents

Publication Publication Date Title
FR2114151A5 (OSRAM)
FR2104108A5 (OSRAM)
FR2108658A5 (OSRAM)
FR2105802A5 (OSRAM)
FR2123270B1 (OSRAM)
FR2108464A5 (OSRAM)
FR2080731B1 (OSRAM)
FR2114021A1 (OSRAM)
FR2077046A5 (OSRAM)
FR2082383A5 (OSRAM)
FR2081047B1 (OSRAM)
HU163364B (OSRAM)
HU163722B (OSRAM)
HU163886B (OSRAM)
FR2113000A5 (OSRAM)
FR2113900A1 (OSRAM)
FR2116434B1 (OSRAM)
FR2100084A5 (OSRAM)
FR2066176A5 (OSRAM)
FR2082431A5 (OSRAM)
HU163659B (OSRAM)
FR2113973A1 (OSRAM)
FR2090677A5 (OSRAM)
FR2093462A5 (OSRAM)
FR2113903B1 (OSRAM)